New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
Nairobi/Khartoum - 12 September 2018 Trial to take place in Sudan, which has the world’s highest rates of this highly stigmatizing disease A clinical trial to find a better treatment for severe or chronic cases of post kala-azar dermal leishmaniasis (PKDL) in Africa has begun in Dooka, Sudan. The objective of this clinical trial, which is being conducted by the DNDand the Institute for Endemic Diseases at the University of Khartoum, is to shorten the length of hospitalization for PKDL, and deliver a treatment that is safer to use and easier to administer.
New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
Recife, Brazil - September 2018 DNDi and the Oswaldo Cruz Foundation, along with diverse national stakeholders, are partnering to improve access to diagnosis and treatment for Chagas disease in Brazil. The collaborative project was launched during the 54th Congress of the Brazilian Society of Tropical Medicine held in the city of Recife in northeast Brazil.
DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
Malaysia takes the lead on a public health approach to hepatitis C with new initiative to enhance diagnosis & treatment
Malaysia takes the lead on a public health approach to hepatitis C with new initiative to enhance diagnosis & treatment
New agreement between Clinical Research Malaysia & FIND on R&D for hepatitis C diagnostic tests continues an existing Malaysian partnership with DNDi for hepatitis C treatment The Foundation for Innovative New Diagnostics (FIND) and Clinical Research Malaysia (CRM), both DNDi partners, recently signed a memorandum of understanding (MoU) to collaborate in the research and development of an innovative hepatitis C diagnostic testing strategy.
Malaysia takes the lead on a public health approach to hepatitis C with new initiative to enhance diagnosis & treatment
FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Amsterdam/Geneva - 23 July 2018 Initiative in Malaysia to enhance country's public health approach to hepatitis C FIND and the DNDi will partner to generate evidence that will support policy change and scale up of hepatitis C diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment.
FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
See all news

Scientific Articles

See all scientific articles

Events

  • 11th DNDi Partners’ Meeting: From innovation to access in Africa – the way forward 4 October 2018 Kampala, Uganda DNDi’s biannual partners’ meeting will bring together some 250-300 health leaders, policy-makers, researchers, civil society groups, product developers, and donors. Meeting sessions will highlight the significant changes made and those still needed in the landscape of research and development, capacity building and strengthening, and access to medicines for neglected diseases and patients on the African continent.
  • ASTMH 2018

    67th Annual Meeting

    28 October - 1 November 2018 New Orleans, USA Nathalie Strub-Wourgaft, NTD Director - presentation on fexinidazole in a symposium on sleeping sickness elimination Colin Forsyth, Chagas Epidemiologist, Sergio Sosa Estani, Head of Chagas Clinical Programme, Eric Chatelain, Head of Drug Discovery Programme - symposium on screening and diagnosis of Chagas disease Poster presentations on Chagas and onchocerciasis
See all events